Abstract
Chronic glucocorticoid therapy causes rapid bone loss and clinical osteoporosis. We previously found that dexamethasone, a potent glucocorticoid, increased renal expression of vitamin D-24-hydroxylase, which degrades such vitamin D metabolites as 25-hydroxyvitamin D3 and 1α,25-dihydroxyvitamin D3 (1,25[OH]2D3). We therefore investigated the mechanisms of this increase in UMR-106 osteoblast-like cells and LLC-PK1 kidney cells. To induce 24-hydroxylase expression, 1,25(OH)2D3 (10−7 M) and dexamethasone were added simultaneously to the medium of LLC-PK1 cells, and 24 h before dexamethasone treatment, 1,25(OH)2D3 was added to the medium of UMR-106 cells. Dexamethasone dose dependently increased 24-hydroxylase mRNA and enzymatic activity in 1,25(OH)2D3-treated LLC-PK1 and UMR-106 cells. Maximal stimulation was observed with 10−6 M dexamethasone in both cell lines. The addition of 10−6 M dexamethasone significantly increased the abundance of 24-hydroxylase mRNA by 24 and 8 h in 1,25(OH)2D3-treated LLC-PK1 and UMR-106 cells, respectively. Stimulation for dexamethasone in UMR-106 cells persisted for up to 48 h. Dexamethasone stimulation of 24-hydroxylase mRNA expression in UMR-106 cells was abolished by pretreatment with cycloheximide, an inhibitor of protein synthesis. Northern and Western analyses indicated that 10−6 M dexamethasone markedly increased the abundance of c-fos mRNA at 20 min and c-fos protein concentration at 60 min in 1,25(OH)2D3-treated UMR-106 cells but only slightly induced the abundance of c-jun mRNA. The addition of phorbol 12-myristate 13-acetate increased mRNA expression for both c-fos and 24-hydroxylase in 1,25(OH)2D3-treated UMR-106 cells. The effect of dexamethasone on 24-hydroxylase mRNA expression was blocked by RO31-8220, a specific inhibitor of protein kinase C. Thus, dexamethasone in the presence of 1,25(OH)2D3 enhances expression of 24-hydroxylase in UMR-106 osteoblastic cells via new protein synthesis. The mechanism of this effect appears to involve activation of the AP-1 site by increased c-fos protein.
Similar content being viewed by others
References
Lukert, B. P. and Raisz, L. G. (1990). Ann. Intern. Med. 112, 352–364.
Reid, I. R. (1997). Eur. J. Endocrinol. 137, 209–217.
Canalis, E. (1996). J. Clin. Endocrinol. Metab. 81, 3441–3447.
Conaway, H. H., Grigorie, D., and Lerner, U. H. (1996). J. Bone Miner. Res. 11, 1419–1429.
Kaji, H., Sugimoto, T., Kanatani, M., Nishiyama, K., and Chihara, K. (1997). J. Bone Miner. Res. 12, 734–741.
Kim, C. H., Cheng, S. L., and Kim, G. S. (1999). J. Endocrinol. 162, 371–379.
Jones, G., Strugnell, S. A., and DeLuca, H. F. (1998). Physiol. Rev. 78, 1193–1231.
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., and Jurutka, P. W. (1998). J. Bone Miner. Res. 13, 325–349.
Ono, T., Tanaka, H., Yamate, T., Nagai, Y., Nakamura, T., and Seino, Y. (1996). Endocrinology 137, 2633–2637.
Bikle, D. D., Halloran, B., Fong, L., Steinbach, L., and Shellito, J. (1993). J. Clin. Endocrinol. Metab. 76, 456–461.
Cosman, F., Nieves, J., Herbert, J., Shen, V., and Lindsay, R. (1994). J. Bone Miner. Res. 9, 1097–1105.
Seeman, E., Kumar, R., Hunder, G. G., Scott, M., Heath, H. III, and Riggs, B. L. (1980). J. Clin. Invest. 66, 664–669.
Prummel, M. F., Wiersinga, W. M., Lips, P., Sanders, G. T. B., and Sauerwein, H. P. (1991). J. Clin. Endocrinol. Metab. 72, 382–386.
Chesney, R. W., Mazess, R. B., Hamstra, A. J., DeLuca, H. F., and O’Reagan, S. (1978). Lancet ii, 1123–1125.
Morris, H. A., Need, A. G., O’Loughlin, P. D., Horowitz, M., Bridges, A., and Nordin, B. E. C. (1990). Calcif. Tissue Int. 46, 305–308.
Akeno, N., Matsunuma, A., Maeda, T., Kawane, T., and Horiuchi, N. (2000). J. Endocrinol. 164, 339–348.
Akeno, N., Saikatsu, S., Kawane, T., and Horiuchi, N. (1997). Endocrinology 138, 2233–2240.
Makin, G., Lohnes, D., Byford, V., Ray, R., and Jones, G. (1989). Biochem. J. 262, 173–180.
Colston, K. and Feldman, D. (1982). J. Biol. Chem. 257, 2504–2508.
Chandler, J. S., Chandler, S. K., Pike, J. W., and Haussler, M. R. (1984). J. Biol. Chem. 259, 2214–2222.
Nishimura, A., Shink, T., Jin, C. H., Ohyama, Y., Noshiro, M., Okuda, K., and Suda, T. (1994). Endocrinology 134, 1794–1799.
Armbrecht, H. J., Wongsurawat, V. J., Hodam, T. L., and Wongsurawat, N. (1996). FEBS Lett. 393, 77–80.
Armbrecht, H. J., Hodam, T. L., Boltz, M. A., Partridge, N. C., Brown, A. J., and Kumar, V. B. (1998). Endocrinology 139, 3375–3381.
St-Arnaud, R., Arabian, A., Travers, R., Barletta, F., Raval-Pandya, M., Chapin, K., Depovere, J., Mathieu, C., Christakos, S., Demay, M. B., and Glorieux, F. H. (2000). Endocrinology 141, 2658–2666.
Chen, M. L., Boltz, M. A., and Armbrecht, H. J. (1993). Endocrinology 132, 1782–1788.
Armbrecht, H. J., Boltz, M. A., Hodam, T. L., and Kumar, V. B. (2001). J. Endocrinol. 169, 145–151.
Fitzgerald, J., Dietz, T. J., and Hughes-Fulford, M. (2000). Endocrinology 141, 291–298.
Zierold, C., Darwish, H. M., and DeLuca, H. F. (1994). Proc. Natl. Acad. Sci. USA 91, 900–902.
Zierold, C., Darwish, H. M., and DeLuca, H. F. (1995). J. Biol. Chem. 270, 1675–1678.
Ohyama, Y., Ozono, K., Uchida, M., Yoshimura, M., Shinki, T., Suda, T., and Yamamoto, O. (1996). J. Biol. Chem. 271, 30,381–30,385.
Liu, M. and Freedman, L. P. (1994). Mol. Endocrinol. 8, 1593–1604.
Chen, K. S. and DeLuca, H. F. (1995). Biochim. Biophys. Acta 1263, 1–9.
McCarthy, T. L., Centrella, M., and Canalis, E. (1990). Endocrinology 126, 1569–1575.
Delany, A. M. and Canalis, E. (1995). Endocrinology 136, 4776–4781.
Swolin, D., Brantsing, C., Matejka, G., and Ohlsson, C. (1996). J. Endocrinol. 149, 397–403.
Bellows, C. G., Aubin, J. E., and Heersche, J. N. M. (1987). Endocrinology 121, 1985–1992.
Cheng, S.-L., Yang, J. W., Rifas, L., Zhang, S.-F., and Avioli, L. V. (1994). Endocrinology 134, 277–286.
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J. (1999). Endocrine Rev. 20, 345–357.
Thomason, B. M., Atkinson, S. J., Reynolds, J. J., and Meikle, M. C. (1987). Biochem. Biophys. Res. Commun. 148, 596–602.
Uchida, M., Shima, M., Chikazu, D., Fujieda, A., Obara, K., Suzuki, H., Nagai, Y., Yamato, H. and Kawaguchi, H. (2001). J. Bone Miner. Res. 16, 221–230.
Matsumoto, T., Igarashi, C., Takeuchi, Y., Harada, S., Kikuchi, T., Yamato, H., and Ogata, E. (1991). Bone 12, 27–32.
Chen, T. L. and Fry, D. (1999). Calcif. Tissue Int. 64, 304–309.
Kawane, T. and Horiuchi, N. (1999). Endocrinology 140, 871–879.
Tomon, T., Tenenhouse, H. S., and Jones, G. (1990). Endocrinology 126, 2868–2875.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurahashi, I., Matsunuma, A., Kawane, T. et al. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1α,25-dihydroxyvitamin D3 . Endocr 17, 109–118 (2002). https://doi.org/10.1385/ENDO:17:2:109
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:17:2:109